Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.1B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.04B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 4 |
iShares China Large-Cap ETF
FXI
|
+$255M |
| 5 |
ARK Innovation ETF
ARKK
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$430M |
| 2 |
Microsoft
MSFT
|
+$365M |
| 3 |
Intel
INTC
|
+$335M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$333M |
| 5 |
Mercado Libre
MELI
|
+$309M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.43% |
| 2 | Healthcare | 5.69% |
| 3 | Financials | 4.7% |
| 4 | Consumer Discretionary | 4.61% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
PVH
PVH
$4.01B
| $1.63M | ﹤0.01% |
18,285
-4,214
| -19% | -$344K |
|
2127
Terreno Realty
TRNO
$7.65B
| $1.63M | ﹤0.01% |
25,193
-43,943
| -64% | -$2.75M |
|
|
LIVB
2128
DELISTED
LIV Capital Acquisition Corp. II Class A Ordinary Shares
LIVB
| $1.63M | ﹤0.01% |
155,800
-20,000
| -11% | -$207K |
|
2129
Kinsale Capital Group
KNSL
$8.11B
| $1.62M | ﹤0.01% |
5,412
+1,073
| +25% | +$314K |
|
|
DOC
2130
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $1.62M | ﹤0.01% |
108,326
+32,061
| +42% | +$484K |
|
2131
Bloom Energy
BE
$61B
| $1.62M | ﹤0.01% |
81,088
+34,641
| +75% | +$759K |
|
|
EVE
2132
DELISTED
EVe Mobility Acquisition Corp
EVE
| $1.61M | ﹤0.01% |
154,489
-19,094
| -11% | -$198K |
|
2133
AB InBev
BUD
$166B
| $1.61M | ﹤0.01% |
24,124
+14,847
| +160% | +$897K |
|
2134
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.3B
| $1.61M | ﹤0.01% |
14,725
+1,663
| +13% | +$181K |
|
2135
iShares Core S&P US Value ETF
IUSV
$27.2B
| $1.61M | ﹤0.01% |
21,789
-679
| -3% | -$50K |
|
2136
ArcBest
ARCB
$3.17B
| $1.61M | ﹤0.01% |
17,382
-1,813
| -9% | -$163K |
|
2137
JetBlue
JBLU
$2.29B
| $1.6M | ﹤0.01% |
219,881
-127,438
| -37% | -$1.01M |
|
|
TRML
2138
DELISTED
Tourmaline Bio
TRML
| $1.6M | ﹤0.01% |
84,996
+84,973
| +369,448% | +$1.4M |
|
|
SHAP
2139
DELISTED
Spree Acquisition Corp. 1 Limited
SHAP
| $1.59M | ﹤0.01% |
149,218
-18,482
| -11% | -$192K |
|
2140
CALL
Archer Daniels Midland
ADM
$38.9B
| $1.59M | ﹤0.01% |
+20,000
| New | +$1.63M |
|
|
2141
PUT
Archer Daniels Midland
ADM
$38.9B
| $1.59M | ﹤0.01% |
+20,000
| New | +$1.63M |
|
2142
GFL Environmental
GFL
$14.9B
| $1.59M | ﹤0.01% |
46,062
+11,028
| +31% | +$348K |
|
2143
Suzano
SUZ
$10.4B
| $1.59M | ﹤0.01% |
193,100
-13,453
| -7% | -$120K |
|
2144
Allison Transmission
ALSN
$9.57B
| $1.58M | ﹤0.01% |
34,955
+1,880
| +6% | +$84.5K |
|
2145
ESCO Technologies
ESE
$8.07B
| $1.58M | ﹤0.01% |
16,517
-926
| -5% | -$86K |
|
2146
GATX Corp
GATX
$6.45B
| $1.57M | ﹤0.01% |
14,310
+7,276
| +103% | +$793K |
|
2147
Corcept Therapeutics
CORT
$12.7B
| $1.57M | ﹤0.01% |
72,686
-2,072
| -3% | -$45.4K |
|
2148
East-West Bancorp
EWBC
$17.9B
| $1.57M | ﹤0.01% |
28,355
-47,607
| -63% | -$3.29M |
|
2149
XPO
XPO
$23.4B
| $1.57M | ﹤0.01% |
49,139
+9,324
| +23% | +$336K |
|
2150
CALL
Elevance Health
ELV
$81.6B
| $1.56M | ﹤0.01% |
3,400
-18,200
| -84% | -$8.66M |
|
Similar funds
Citigroup's Q1 2023 Portfolio in Review
As of Q1 2023, Citigroup held 6,117 positions worth $143B, up 14% from $126B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Citigroup deployed $6.55B of net new capital in Q1 2023, opening 347 new positions and adding to 2,011 existing holdings. Its largest new stake was Direxion Daily S&P 500 Bull 2X ETF: 350,003 shares worth $28M.
By sector, the portfolio is most concentrated in Technology at 9.4% of assets, down from 9.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street Consumer Staples Select Sector SPDR ETF, an estimated $430M trimmed.
- Citigroup's largest Q1 2023 buy was Direxion Daily S&P 500 Bull 2X ETF: 350,003 shares worth $28M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $1.1B increase.
- Citigroup's biggest Q1 2023 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $430M.
- Citigroup fully exited LHC Group LLC in Q1 2023, selling an estimated $28.8M.
- Citigroup's ten largest holdings make up 34% of its $143B portfolio in Q1 2023.
- Citigroup opened 347 new positions and closed 668 in Q1 2023.
- Citigroup's portfolio value rose 14% quarter-over-quarter to $143B.
Based on Citigroup's 13F filing for Q1 2023, filed 11 May 2023.